Retrospective Cohort Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Nov 7, 2018; 24(41): 4691-4697
Published online Nov 7, 2018. doi: 10.3748/wjg.v24.i41.4691
Figure 1
Figure 1 Bar diagram of post endoscopic retrograde cholangiopancreatography adverse events and hospital mortality percentages between end-stage renal disease, chronic kidney disease, and control. CKD: Chronic kidney disease; ESRD: End-stage renal disease; PEP: Post endoscopic retrograde cholangiopancreatography pancreatitis.